Acalypha Wilkesiana ‘Java White’: Identification of Some Bioactive Compounds by Gc-Ms and Their Effects on Key Enzymes Linked to Type 2 Diabete

1. IDF Diabetes Atlas, 8th ed., International Diabetes Federation, Brussels 2017; http://www.diabetesatlas. org; last access date April 30, 2018Search in Google Scholar

2. G. Roglic, WHO Global report on diabetes: A summary, Int. J. Noncom. Dis. 1 (2016) 3-8.10.4103/2468-8827.184853Search in Google Scholar

3. M. Lakshmi, K. Rani and T. Reddy, A review on diabetes mellitus and the herbal plants used for its treatment, Asian J. Pharm. Clin. Res. 5 (2012) 15-21.Search in Google Scholar

4. A. S. Al-Goblan, M. A. Al-Alfi and M. Z. Khan, Mechanism linking diabetes mellitus and obesity, Diab. Metab. Syndr. Obes. 7 (2014) 587-591; https://doi.org/10.2147/dmso.s6740010.2147/DMSO.S67400Search in Google Scholar

5. D. K. Tobias, A. Pan, C. L. Jackson, E. J. O’reilly, E. L. Ding, W. C. Willett, J. E. Manson and F. B. Hu, Body-mass index and mortality among adults with incident type 2 diabetes, New Engl. J. Med. 370 (2014) 233-244; https://doi.org/10.1056/NEJMoa130450110.1056/NEJMoa1304501Search in Google Scholar

6. E. Levelt, M. Pavlides, R. Banerjee, M. Mahmod, C. Kelly, J. Sellwood, R. Ariga, S. Thomas, J. Francis and C. Rodgers, Ectopic and visceral fat deposition in lean and obese patients with type 2 diabetes, J. Am. Coll. Cardiol. 68 (2016) 53-63; https://doi.org/10.1016/j.jacc.2016.03.59710.1016/j.jacc.2016.03.597Search in Google Scholar

7. S. Kumar, S. Narwal, V. Kumar and O. Prakash, α-glucosidase inhibitors from plants: A natural approach to treat diabetes, Pharmacogn. Rev. 9 (2011) 19-29; https://doi.org/10.4103/0973-7847.7909610.4103/0973-7847.79096Search in Google Scholar

8. M. Yilmazer-Musa, A. M. Griffith, A. J. Michels, E. Schneider and B. Frei, Inhibition of α-amylase and α-glucosidase activity by tea and grape seed extracts and their constituent catechins, J. Agric. Food Chem. 60 (2012) 8924-8929; https://doi.org/doi:10.1021/jf301147nSearch in Google Scholar

9. M. Safavi, A. Foroumadi and M. Abdollahi, The importance of synthetic drugs for type 2 diabetes drug discovery, Expert Opin. Drug Discov. 8 (2013) 1339-1363; https://doi.org/10.1517/17460441.2013.83788310.1517/17460441.2013.837883Search in Google Scholar

10. J. H. Wu, C. Foote, J. Blomster, T. Toyama, V. Perkovic, J. Sundström and B. Neal, Effects of sodiumglucose cotransporter-2 inhibitors on cardiovascular events, death, and major safety outcomes in adults with type 2 diabetes: a systematic review and meta-analysis, Lancet Diab. Endocrinol. 4 (2016) 411-419; https://doi.org/10.1016/S2213-8587(16)00052-810.1016/S2213-8587(16)00052-8Search in Google Scholar

11. Z. Bahadoran, P. Mirmiran and F. Azizi, Dietary polyphenols as potential nutraceuticals in management of diabetes: a review, J. Diabetes Metab. Disord. 12 (2013) Article ID 43 (9 pages); https://doi.org/10.1186/2251-6581-12-4310.1186/2251-6581-12-43796845223938049Search in Google Scholar

12. J. O. Olukunle, E. B. Jacobs and J. A. Oyewusi, Hypoglycemic and hypolipidemic effects of Acalypha wilkesiana leaves in alloxan induced diabetic rats, FASEB J. 30 (2016) Abstract No. 1269.3; https://doi.org/abs/10.1096/fasebj.30.1_supplement.1269.3Search in Google Scholar

13. J. C. Ikewuchi, E. N. Onyeike, A. A. Uwakwe and C. C. Ikewuchi, Effect of aqueous extract of the leaves of Acalypha wilkesiana ‘Godseffiana’ Muell Arg (Euphorbiaceae) on the hematology, plasma biochemistry and ocular indices of oxidative stress in alloxan induced diabetic rats, J. Ethnopharmacol. 137 (2011) 1415-1424; https://doi.org/10.1016/j.jep.2011.08.01510.1016/j.jep.2011.08.01521864665Search in Google Scholar

14. U. Odoh, R. I. Ndubuokwu, S. I. Inya-Agha, P. O. Osadebe, P. F. Uzor and M. Ezejiofor, Antidiabetic activity and phytochemical screening of Acalypha wilkesiana (Euphorbiaceae) Mull Arg. roots in alloxan-induced diabetic rats, Sci. Res. Essays 9 (2014) 204-212; https://doi.org/10.5897/SRE2014.582410.5897/SRE2014.5824Search in Google Scholar

15. A. Mohammed, M. A. Ibrahim and M. S. Islam, African medicinal plants with antidiabetic potentials: A review, Planta Med. 80 (2014) 354-377; https://doi.org/10.1055/s-0033-136033510.1055/s-0033-136033524535720Search in Google Scholar

16. K. K. Igwe, A. J. Madubuike, I. E. Otuokere, C. Ikenga and F. J. Amaku, Studies on the medicinal plant Acalypha wilkesiana ethanol extract phytocomponents by GCMS analysis, Global J. Sci. Front. Res. D Agric. Vet. 16 (2016) 49-55.10.18535/ijsrm/v4i5.03Search in Google Scholar

17. A. O. Ademiluyi and G. Oboh, Soybean phenolic-rich extracts inhibit key-enzymes linked to type 2 diabetes (α-amylase and α-glucosidase) and hypertension (angiotensin I converting enzyme) in vitro, Exp. Toxicol. Pathol. 65 (2013) 305-309; https://doi.org/10.1016/j.etp.2011.09.00510.1016/j.etp.2011.09.00522005499Search in Google Scholar

18. L. J. Shai, P. Masoko, M. P. Mokgotho, S. R. Magano, A. Mogale, N. Boaduo and J. N. Eloff, Yeast alpha glucosidase inhibitory and antioxidant activities of six medicinal plants collected in Phalaborwa, South Africa, S. Afr. J. Bot. 76 (2010) 465-470; https://doi.org/10.1016/j.sajb.2010.03.00210.1016/j.sajb.2010.03.002Search in Google Scholar

19. Y. S. Kim, Y. M. Lee, H. Kim, J. Kim, D. S. Jang, J. H. Kim and J. S. Kim, Anti-obesity effect of Morus bombycis root extract: Anti-lipase activity and lipolytic effect, J. Ethnopharmacol. 130 (2010) 621-624; https://doi.org/10.1016/j.jep.2010.05.05310.1016/j.jep.2010.05.05320669373Search in Google Scholar

20. P. Panda, M. Rath, A. Pal, T. Sharma and D. Das, GC-MS analysis of bioactive compounds in the methanol extract of Clerodendrum viscosum leaves, Pharmacogn. Res. 7 (2015) 110-113; https://doi.org/10.4103/0974-8490.14722310.4103/0974-8490.147223428563925598644Search in Google Scholar

21. P. Olofsson, M. Hultqvist, L. I. Hellgren and R. Holmdahl, Phytol: A Chlorophyll Component with Anti-inflammatory and Metabolic Properties, in Recent Advances in Redox Active Plant and Microbial Products (Eds. C. Jacob, G. K irsch, A. Slusarenko, P. Winyard a nd T. Burkholz), Springer, Dordrecht 2014, Chapter 13, pp. 345-359.10.1007/978-94-017-8953-0_13Search in Google Scholar

22. T. Takato, K. Iwata, C. Murakami, Y. Wada and F. Sakane, Chronic administration of myristic acid improves hyperglycemia in the Nagoya-Shibata-Yasuda mouse model of congenital type 2 diabetes, Diabetologia 60 (2017) 2076-2083; https://doi.org/10.1007/s00125-017-4366-410.1007/s00125-017-4366-428707095Search in Google Scholar

23. J. Fotie and D. S. Bohle, Pharmacological and biological activities of xanthones, Anti-Infect. Agents Med. Chem. 5 (2006) 15-31; https://doi.org/10.2174/18715210677475556310.2174/187152106774755563Search in Google Scholar

24. G. Mahendran, M. Manoj, E. Murugesh, R. S. Kumar, P. Shanmughavel, K. R. Prasad and V. N. Bai, In vivo anti-diabetic, antioxidant and molecular docking studies of 1,2,8-trihydroxy-6-methoxy xanthone and 1,2-dihydroxy-6-methoxyxanthone-8-O-β-D-xylopyranosyl isolated from Swertia corymbosa, Phytomedicine 21 (2014) 1237-1248; https://doi.org/10.1016/j.phymed.2014.06.01110.1016/j.phymed.2014.06.01125172785Search in Google Scholar

25. A. Mahammed, D. Kumar and S. I. Rizvi, Antidiabetic potential of some less commonly used plants in traditional medicinal systems of India and Africa, J. Intercult. Ethnopharmacol. 4 (2015) 78-85; https://doi.org/10.5455/jice.2014103001524110.5455/jice.20141030015241456676926401390Search in Google Scholar

26. C. Luo, H. Zheng, S. Mao, M. Yang, C. Luo and H. Chen, Xanthones from Swertia mussotii and their α-glycosidase inhibitory activities, Planta Med. 80 (2014) 201-208; https://doi.org/0.1055/s-0033-136017310.1055/s-0033-1360173Search in Google Scholar

27. N. Artanti, S. Tachibana, L. B. S. Kardono and H. Sukiman, Isolation of alpha-glucosidase inhibitors roduced by an endophytic fungus, Colletotrichum sp. TSC13 from Taxus sumatrana, Pak. J. Biol. ci. 15 (2012) 673-679; https://doi.org/10.3923/pjbs.2012.673.67910.3923/pjbs.2012.673.67924171248Search in Google Scholar

28. R. Mopuri, M. Ganjyagi, B. Meriga, N. A. Koorbanally and M. S. Islam, The effects of Ficus carica n the activity of enzyme related to metabolic syndrome, J. Food Drug Anal. 26 (2018) 201-210; ttps://doi.org/10.1016/j.jfda.2017.03.00110.1016/j.jfda.2017.03.00129389556Search in Google Scholar

29. T. Chen, H. Li, C. Chen, L. Wei and Y. Li, Long scale preparation of specific xanthone from Swertia usotli and evaluation of its α-glucosidase inhibitory activity, J. Chromatogr. Sci. 55 (2017) 638- 644; https://doi.org/10.1093/chromsci/bmx02010.1093/chromsci/bmx02028334929Search in Google Scholar

30. N. Payghami, S. Jamili, A. Rustaiyan, S. Saeidnia, M. Nikan and A. R. Gohari, Alpha-amylase nhibitory activity and sterol composition of the marine algae, Sargassum glaucescens, Pharmacogn. es. 7 (2015) 314-321; https://doi.org/10.4103/0974-8490.16789310.4103/0974-8490.167893466050926692744Search in Google Scholar

31. R. R. Wing, W. Lang, T. A. Wadden, M. Safford, W. C. Knowler, A. G. Bertoni, J. O. Hill, F. L. Brancati, A. Peters and L. Wagenknecht, Benefits of modest weight loss in improving cardiovascular isk factors in overweight and obese individuals with type 2 diabetes, Diabetes Care 34 (2011) 481-1486; https://doi.org/10.2337/dc10-241510.2337/dc10-2415312018221593294Search in Google Scholar

32. M. A. Ado, F. Abas, A. S. Mohammed and H. M. Ghazali, Anti- and pro-lipase activity of selected edicinal, herbal and aquatic plants, and structure elucidation of an anti-lipase compound, Molecules 8 (2013) 14651-14669; https://doi.org/10.3390/molecules18121465110.3390/molecules181214651627011124287996Search in Google Scholar

33. K. Omage, M. A. Azeke and S. O. Omage, Evaluation of the efficacy of Acalypha wilkesiana leaves n managing cardiovascular disease risk factors in rabbits exposed to salt-loaded diets. Phytomedicine (2018) 1-7; https://doi.org/10.1186/s40816-018-0060-410.1186/s40816-018-0060-4Search in Google Scholar